| |
| |
|
| Insider
Information: |
Reed Elizabeth E |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
77,308 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$469,823 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
77,308 |
|
|
| Total
Value |
$469,823 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 12.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Senior Director, Legal... |
2006-04-10 |
1,038 |
2006-01-09 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
|
2024-02-01 |
76,270 |
2017-01-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-05-14 |
4 |
AS |
$17.75 |
$9,319 |
D/D |
(525) |
20,033 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-05-15 |
4 |
AS |
$17.71 |
$9,298 |
D/D |
(525) |
19,508 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2020-05-11 |
4 |
AS |
$14.95 |
$7,849 |
D/D |
(525) |
26,483 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-01-05 |
4 |
AS |
$26.65 |
$18,335 |
D/D |
(688) |
24,743 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-01-06 |
4 |
AS |
$27.01 |
$18,583 |
D/D |
(688) |
24,055 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-01-08 |
4 |
AS |
$24.09 |
$18,068 |
D/D |
(750) |
17,077 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-01-09 |
4 |
AS |
$23.82 |
$17,865 |
D/D |
(750) |
16,327 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2020-01-07 |
4 |
AS |
$13.94 |
$10,455 |
D/D |
(750) |
18,758 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2020-01-08 |
4 |
AS |
$15.14 |
$11,355 |
D/D |
(750) |
18,008 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2023-05-10 |
4 |
AS |
$16.59 |
$13,687 |
D/D |
(825) |
56,611 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-02-12 |
4 |
AS |
$21.50 |
$19,006 |
D/D |
(884) |
14,558 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2019-02-11 |
4 |
AS |
$21.38 |
$18,921 |
D/D |
(885) |
15,442 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-05-10 |
4 |
AS |
$21.51 |
$19,359 |
D/D |
(900) |
42,888 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2018-01-05 |
4 |
S |
$24.04 |
$22,646 |
D/D |
(942) |
9,058 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-05-12 |
4 |
AS |
$21.51 |
$22,584 |
D/D |
(1,050) |
41,838 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2020-05-12 |
4 |
AS |
$16.98 |
$17,960 |
D/D |
(1,052) |
25,431 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2022-01-31 |
4 |
AS |
$27.40 |
$36,990 |
D/D |
(1,350) |
43,788 |
0 |
% |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2021-08-17 |
4 |
S |
$17.12 |
$24,086 |
D/D |
(1,407) |
37,548 |
0 |
% |
|
| ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-09 |
4 |
AS |
$10.00 |
$15,004 |
D/D |
(1,500) |
0 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-09 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
1,500 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
• – – |
2006-02-13 |
4 |
AS |
$10.81 |
$16,260 |
D/D |
(1,500) |
0 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
• – – |
2006-02-13 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
1,500 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
• – – |
2006-04-10 |
4 |
OE |
$2.95 |
$4,425 |
D/D |
1,500 |
2,538 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Senior Director, Legal Affairs |
• – – |
2006-04-10 |
4 |
AS |
$13.50 |
$20,507 |
D/D |
(1,500) |
1,038 |
|
- |
|
| TVTX |
Travere Therapeutics, Inc |
SVP, GC & Corporate Secretary |
• – – |
2020-09-22 |
4 |
AS |
$18.59 |
$27,885 |
D/D |
(1,500) |
26,931 |
0 |
% |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
